SWOG clinical trial number
SWOG-8721

A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer

Closed
Phase
II
Accrual
69%
Published
Abbreviated Title
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer
Activated
09/01/1987
Closed
09/01/1991

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1996

Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group study.

TR Fleming;TD Brown;SW Ross;JS Macdonald Investigational New Drugs 13:363-365

1992

A phase II trial of trimetrexate in the treatment of esophageal cancer: A Southwest Oncology Group trial.

T Brown;T Fleming;C Tangen;J Macdonald ASCO 11:166(#479)

Other Clinical Trials

SWOG Clinical Trial Number
S1815
SWOG Clinical Trial Number
S1613
SWOG Clinical Trial Number
CTSU/R1112

Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma

Research Committee(s)
Gastrointestinal Cancer
Symptom Control and Quality of Life
Activated
06/15/2016
Open
Phase
III